KEY FIGURES
Africa within the global pharmaceutical market 21.8% Europe
49%
21.7%
2.2%
North America
AsiaPacific
Turkey, Middle-EastEurasia
In 2016, global pharmaceutical revenues totalled over US$ 1,105 billion and are forecast to reach US$ 1,400 billion by 2021, especially thanks to the growth in “pharmerging” countries1. The African Continent only accounts for 0.7% of this market (ten African countries2 represent 70% of the Continent’s revenues on their own).
4.6%
Latin America
1. China, Brazil, Russia, India, Algeria, Argentina, Colombia, Bangladesh, Indonesia, Mexico, Nigeria, Pakistan, Poland, Saudi Arabia, South Africa, Philippines, Turkey, Romania, Chile, Kazakhstan, Vietnam. 2. Algeria, Egypt, Kenya, Côte d’Ivoire, Libya, Morocco, Nigeria, South Africa, Sudan, Tunisia. Source: IQVIA Institute; World Health Organisation (WHO)
Market size, US$ billions
The African pharmaceutical market is booming
Rest of Africa Top 10 countries1
19.9
1. Algeria, Egypt, Kenya, Côte d’Ivoire, Libya, Morocco, Nigeria, South Africa, Sudan, Tunisia.
0.7%
Africa
The African pharmaceutical market was worth US$ 19.9 billion in 2012 and is forecast to grow to US$ 50 billion by 2020, driven by the Continent’s demographic boom inter alia. Rest of Africa
66.5
Top 15 countries1
5.8
10.4
1. Algeria, Angola, Cameroon, Egypt, Ethiopia, Ghana, Kenya, Libya, Marocco, Nigeria, South Africa, Sudan, Tanzania, Tunisia, Uganda
52.2
7.8
7.1
2.5 4.2
17.5
1.2
3.0
3.0
7.9
14.1
14.5
45.1
58.7
2000
2006
2012
2010
2020, REALISTIC
2020, OPTIMISTIC
Source: McKinsey, Africa: A Continent of Opportunity for Pharma and Patients, April 2015
18 PRIVATE SECTOR & DEVELOPMENT
Source: McKinsey, Africa: A Continent of Opportunity for Pharma and Patients, April 2015